The Latest Breaking News on Pharma

Chris Hammans started coaching the side after his son Lewis took up the sport. Now, after Lewis’s death, Chris is determined to continue

Britain, the first country to approve a coronavirus vaccine in late 2020, has now also given the first green light to a variant-adapted shot that targets both the original and Omicron version of the virus.

JCVI will decide whether to use Moderna-manufactured jab in planned autumn booster campaign

What’s next, the author asks, now the US has ‘a generation of users that started with heroin and fentanyl’

New technology involving miniature human organs built in a lab is a step towards better treatments and ending a contentious practice

By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT

Drug can help prevent infection in people who are immunocompromised but government says data is lacking

Germany’s health minister says European Union drug regulators may authorize the use of vaccines that are effective against two variants of the coronavirus

Around 38,000 customers have filed lawsuits against the healthcare giant

Last year the company halted sales in the US and Canada

The U.S. Food and Drug Administration (FDA) has accepted the Menarini Group and Radius Health’s (NASDAQ:RDUS), New Drug Application (NDA) for elacestrant for patients with ER+/HER2- advanced or metastatic breast cancer. The agency has granted Priority Review designation and assigned a target action date of February 17, 2023. Radius Health…